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Thi gh muscle weakness has been commonly observed in individuals with knee osteoarthritis (KOA). In literature reviews, low thigh muscle strength has been identified as a risk factor for incident radiographic 1 and symptomatic KOA. 2 The specific role of thigh muscle weakness in radiographic and/or symptomatic progression of KOA, however, remains elusive. Some studies reported knee extensor weakness to represent a risk factor of radiographic 3 and symptomatic 4 KOA progression in females, but not in males, whereas other studies found no significant association of muscle strength with either radiographic or symptomatic progression. 5, 6 Because radiographic KOA progression and symptomatic KOA progression often occur in combination, these inconsistent observations may reflect a distinct or even differential relationship of thigh muscle strength with different types of progression (i.e., combined and/or isolated symptomatic and/or radiographic) that have not yet been elucidated. Thigh muscle strength may influence symptomatic and radiographic progression differently; knee symptoms and muscle strength are both mediated by the central nervous system, 7 whereas structural disease is not. 8 Greater knowledge on whether indeed thigh muscle weakness is a risk factor for these different types of progression is clinically important, as muscle strength is a potential modifiable risk factor. Identifying distinct relationships between strength and progression may therefore affect current nonpharmacological treatment approaches of KOA. The Foundation for the National Institutes of Health (FNIH) Osteoarthritis (OA) Biomarkers Consortium was established to investigate the predictive validity of various disease progression biomarkers 9 in the Osteoarthritis Initiative (OAI). Having identified OAI participants with combined and isolated radiographic or symptomatic KOA progression, 9 the FNIH consortium provides an ideal platform from which to evaluate the prognostic capacity and association of change of thigh muscle weakness on different types of progression. 10 The specific aims of the current study were to determine (i) whether baseline thigh muscle weakness is a risk factor for combined or isolated radiographic and/or symptomatic progression and (ii) whether there exists a significant association of longitudinal change in thigh muscle strength with concurrent radiographic and/or symptomatic progression versus no KOA progression.
MATERIALS AND METHODS

Participants
This study was ancillary to the FNIH OA Biomarkers Consortium project, consisting of a nested case-control study using OAI data. 9Y11 The OAI is a multicenter longitudinal cohort study with 4796 participants who were examined annually over 4 years using imaging, clinical, and biospecimen (i.e., urine/serum) outcomes. 12 To be eligible for the have at least 1 knee with baseline tibiofemoral Kellgren-Lawrence grade (KLG) 1 to 3 and availability of 24-month radiographs, clinical data, biospecimens, and magnetic resonance imaging. 9 Participants with knee or hip arthroplasty up to 24 months were excluded. A flow diagram detailing FNIH project participant recruitment has been recently published elsewhere. 11 For the current analysis, participants also needed to have knee extensor and flexor strength data at baseline and 24 months, which were available for 527 of the 600 FNIH consortium participants ( Table 1 ). The study was approved by the local institutional review boards at each of the OAI sites, and participants provided informed consent. Severity of KOA (KLG) was assessed by central reading of fixed-flexion radiographs and semiquantitative joint space narrowing (JSN), whereas pain was assessed using the Western Ontario McMasters Osteoarthritis Index (WOMAC) pain subscale. Minimum radiographic joint space width (minJSW) in the medial tibiofemoral compartment was assessed using automated software, 12 with established cross-sectional (intraclass correlation coefficient [ICC], 0.98) and longitudinal (ICC, 0.96) reliability (http://www.oai. ucsf.edi/datarelease/). Knees with lateral compartment JSN grades 2 to 3 at baseline or poorly positioned radiographs were excluded, as this may limit the accuracy of medial tibiofemoral minJSW measurements or result in radiographic misclassification. 13 Radiographic progression was defined as medial compartment minJSW loss of 0.7 mm or greater from baseline to 24, 36, or 48 months. The 0.7-mm threshold was based on the 12-month change distribution in minJSW in OAI control participants; it involves a minimal probability (e10%) of change due to measurement error. 9, 14 Symptomatic progression was defined as a persistent increase of 9 or more points on a 0-to 100-point normalized WOMAC score from baseline to 24, 36, 48, or 60 months, that is, a minimally clinically important difference. 15 Persistent pain cases were those who reported increased pain of 9 or more WOMAC points versus baseline at 2 or more time points from 24 to 60 months. 9 Knees that reached radiographic and symptomatic progression status between baseline and 12 months were excluded. The specific outcome groups are detailed in Table 1 .
Procedures
The maximal isometric extensor and flexor forces (in Newtons [N]) were determined as the maximum of 3 attempts at 60-degree knee flexion (Good Strength Chair; Metitur Oy, Jyväskylä, Finland). Baseline and 24-month data reported in the OAI database were used (clinical data BL/Y2: 0.2.2/3.2.1). 16 Four female participants had flexor strength of less than 10 N (3 at baseline, 1 at 24 months), whereas extensor strength was within a reference range (78Y248 N) in all participants. Because the measurement of flexor strength was likely inaccurate, these 4 observations were excluded from current analyses. Muscle strength data were normalized to body weight (N/kg) for analysis. Because OAI muscle strength measurements were taken at an anatomically consistent location, the isometric force measurements (N/kg) were used directly, and not moments, consistent with previous OAI strength evaluations. 16 The rationale for this was that the lever arm between the load cell and joint center and that between the muscle tendons and joint center both depend on body size; they may thus be assumed to be a If both knees of a participant were in 1 group, one was randomly selected as the index knee for study inclusion. Participants with one knee displaying only radiographic progression and the other knee only pain progression were excluded. Knees selected for the 4 groups were frequency matched to the extent possible using KLG strata 1 to 3 and BMI strata less than 25, 25Y27.5, 27.5Y30, 30Y35, and Q35 kg/m 2 . Group 4 knees could not have radiographic progression, including worsening of lateral compartment JSN, or pain progression in the contralateral knee.
b Control subjects were made up of participants who met all eligibility criteria to be cases except the concurrent radiographic and symptomatic progression criteria.
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Muscle Strength and Knee OA Progression roughly proportional, 16 so that the measured force provides an accurate representation of the actual muscle force. Although the lever arm between the load cell and joint center was documented for some OAI participants, these measurements were available in only 281 (53%) of the 527 participants. Demographic, structural, and pain characteristics of the primary case (group 1) and control groups (groups 1, 2, and 3) were compared using parametric and nonparametric tests as appropriate (based on normality) and W 2 tests for data in contingency tables. The ability of baseline muscle strength to predict progression status was evaluated using logistic regression, after confirming normality. The association of change in muscle strength from baseline to 24 months with concurrent KOA progression status was also evaluated using logistic regression, with both analyses performed separately in male and female participants. Odds ratios (ORs) and 95% confidence intervals (CIs) per SD were reported for each muscle strength outcome after adjusting for age, body mass index (BMI), baseline KLG, and pain frequency status in the past year (none, infrequent, frequent). An OR of more than 1 represents greater odds of KOA progression occurring in the presence of muscle weakness or in the presence of greater strength loss over 24 months. In the primary, prespecified analysis of FNIH data, muscle strength outcomes were compared between primary case knees (group 1) and control knees (groups 2Y4). Secondary analyses compared muscle strength outcomes between combined and isolated radiographic/symptomatic progression groups (group 1, 2, and 3) versus the no-progression group (group 4), respectively. All analyses were performed with SPSS version 22.0 (IBM Corp, Armonk, NY). P G 0.05 was considered significant.
RESULTS
Of the 194 cases and 406 control subjects included in the primary FNIH Biomarker cohort, 173 cases (89%) and 354 control subjects (87%) had muscle strength assessment at both baseline and 24 months (Table 1 ). There were no statistically or clinically relevant differences in age, BMI, baseline KLG, or pain frequency between those who did and did not have muscle strength recorded (P G 0.05). Baseline characteristics of participants included in the current study appear in Table 2 , with the full FNIH cohort baseline data having been published previously. 10, 11 The baseline demographics of the primary cases (group 1) and control subjects (group 2, 3, and 4) were similar ( Table 2 ). The primary cases had more severe OA (KLG and medial JSN) and more pain medication use. Primary cases: knees with radiographic and pain progression (group 1). Control subjects: knees with radiographic but not pain progression (group 2), knees with symptomatic but not radiographic progression (group 3), and knees without radiographic or symptomatic progression (group 4). Values are mean T SD unless otherwise indicated.
a P values represent comparisons between the primary prespecified analysis groups (cases: group 1; control subjects: groups 2, 3, and 4) using independent-samples t tests unless indicated otherwise. Based on pain frequency status in the past year: Frequent pain defined as Bpain, aching or stiffness in or around the knee on most days for 1month or more during the past 12 months[; infrequent pain defined as the above symptoms but at any time in the past 12 months (not on most days for Q1 month).
d Mann-Whitney U test as data not normally distributed.
The mean (95% CI) muscle strength for each of the primary and secondary KOA status groups at baseline and 24 months is shown in Figure 1 . In the primary analysis, baseline muscle strength did not predict combined radiographic and symptomatic progression compared with control subjects without this combination (Table 3) . Male and female primary cases (group 1) and control subjects (groups 2Y4) all lost knee extensor (range of means, j0.26 to j0.40 N/kg) and flexor strength (range, j0.15 to j0.24 N/kg) from baseline to 24 months (P G 0.003). Strength loss over 24 months was not associated with combined radiographic and symptomatic progression case status in male or female participants when compared with those without combined progression (Table 3) .
In secondary comparisons, both baseline knee extensor (adjusted OR [aOR], 1.7; 95% CI, 1.1Y3.3) and flexor weakness (aOR, 2.0; 95% CI, 1.1Y3.3) in male subjects predicted isolated symptomatic progression (group 3) compared with male subjects without symptomatic or radiographic progression Adjusted ORs and 95% CIs per SD. An OR of more than 1 represents greater odds of KOA progression occurring in the presence of muscle weakness or in the presence of greater strength loss over 24 months.
Group 1: knees with both radiographic and symptomatic progression (primary cases); group 2: knees with radiographic progression but not symptomatic progression; group 3: knees with symptomatic progression but not radiographic progression; group 4: knees with neither radiographic nor symptomatic progression (secondary control subjects).
Odds ratios adjusted for baseline age, BMI, KLG, and pain frequency. a Three females with baseline flexion strength G10 N excluded. b Three females with baseline flexion strength G10 N and 1 female with 24-month flexion strength G10 N were excluded. www.ajpmr.com
Muscle Strength and Knee OA Progression (group 4). Female participants with isolated symptomatic progression also had lower baseline extensor strength than all other groups, but the difference did not reach statistical significance in comparison with control subjects without symptomatic or radiographic progression (aOR, 1.4; 95% CI, 0.9Y2.0). Baseline flexor strength of female subjects with isolated symptomatic progression was similar to subjects free of symptomatic and radiographic progression (aOR, 1.3; 95% CI, 0.9Y2.0). Male participants with symptomatic progression started with low baseline extensor strength and lost less knee extensor strength over 24 months than did those in all other groups (Fig. 1 ), but this difference did not reach statistical significance in comparison with those without symptomatic or radiographic progression (aOR, 0.8; 95% CI, 0.5Y1.3). Similar nonsignificant observations were observed in knee extensor strength loss in females with isolated symptomatic progression compared with those free of symptomatic and radiographic progression (aOR, 0.8; 95% CI, 0.6Y1.1). Less loss of knee flexor strength in males between baseline and 24 months was associated with JSN progression compared with those free of symptomatic and radiographic progression (aOR, 0.6; 95% CI-0.4Y0.9), because of the relatively large strength loss in the control subjects (group 4) (Fig. 1) . No such associations between longitudinal change in muscle strength and progression were observed in female participants (Table 3) .
DISCUSSION
In this first evaluation of thigh muscle strength as a predictor of distinct combinations of symptomatic and radiographic progression, results show that the relationship between knee extensor and flexor weakness and KOA progression differs depending on the type of progression evaluated, particularly for males. For example, while baseline and 24-month change in thigh muscle strength in male participants did not predict symptomatic progression in the presence of radiographic progression, both knee extensor and flexor weakness predicted isolated symptomatic progression in the absence of radiographic progression. Because joint effusion, pain, trauma, and decreased activity all lead to muscle weakness in a vicious cycle, these results may also apply to earlier phases of KOA. These results identify a window for potentially lowering risk of symptomatic KOA progression in men.
The findings that knee extensor and flexor strength predicted symptomatic progression in male subjects, but only when simultaneous radiographic progression was actively ruled out, suggest that different mechanisms may drive pain in males with KOA, depending on the type of progression, and thigh muscle strength may affect symptomatic and structural progression differently. The results in males extend recent observations using OAI data that demonstrated thigh muscle strength to be more strongly associated with symptomatic KOA than radiographic KOA. 16 Based on previous relationships between muscle strength and KOA progression reported in females, 3, 4 it was surprising that no relationship was observed between muscle strength and any type of KOA progression in female knees. However, differences in methodology may explain these different results. For example, previous studies have included females without, but at risk of, KOA and therefore evaluated incident symptoms or structural deterioration rather than progression per se. 3, 4 It is conceivable that females at risk of KOA may have different relationships with clinical outcomes from those with established KOA. 17 Furthermore, knee replacement was included in previous progression definitions 3, 4 but not in the current study. The decision to undergo knee replacement is in part driven by factors independent of structural or symptomatic status. Importantly, the results may help explain why few associations between thigh muscle strength and OA progression have been previously observed in males, when different types of progression (i.e., symptomatic vs. radiographic) were analyzed together without being clearly dissected from each other. 3, 4 Based on the results of this study, isolated symptomatic progression and symptomatic progression in combination with radiographic progression should not be considered as one Bsymptomatic entity,[ especially in men. Concurrent change in thigh muscle strength was not associated with the primary outcome of combined symptomatic and radiographic progression. Yet, male participants who lost less knee flexor strength over 24 months exhibited isolated radiographic progression. The perhaps unexpected relationship between less loss of strength and KOA progression in this group may have been due to the low knee flexor strength at baseline, resulting in nonsignificant loss of strength over 24 months, and a larger loss of strength in those with neither radiographic nor symptomatic progression. In females, in contrast, all of the progression groups displayed very similar strength loss trajectories over 24 months.
This study evaluated whether knee extensor or flexor weakness predicts KOA progression because both groups of thigh muscles contribute to knee joint stability. Weakness in either the knee extensors or flexors could reduce neuromuscular control and shock absorption, which may be associated with knee symptoms. On the other hand, given that joint loads are largely determined by muscle force, greater muscle strength may be associated with greater joint loads and hence be related to greater structural (radiographic) progression due to mechanical challenges, which may not immediately translate to knee symptoms. For these reasons, the relationship between muscle strength and the different types of progression may be complex and difficult to elucidate.
A limitation of the current study is that not all participants eligible for the FNIH OA biomarker cohort had muscle strength data recorded at baseline and 24 months. However, more than 85% of primary cases and control subjects were included, and these participants did not differ in terms of age, sex, BMI, baseline pain frequency, or radiographic KOA status from those who did not have muscle strength measurement. Subgrouping males and females separately in all 4 subgroups implied some risk of potential chance findings, given a number of parallel exploratory analyses that were not adjusted for multiple comparisons. However, it was important to analyze males and females separately because of the greater variability in the observed muscle strength when mixing males and females and because previous studies reported that males and females display different muscle strength risk profiles for KOA progression. 3, 4 The main finding that baseline muscle weakness in male participants predicted symptomatic progression was consistent in both knee extensors and flexors, suggesting a genuine relationship between muscle weakness and symptomatic progression in males, and only 2 subgroups had less than 50 participants, with narrow CIs indicating relatively precise estimates of effect sizes ( Table 3) . Some of the findings may also be influenced by the presence of patellofemoral OA, which was not assessed in the current study because skyline radiographs, used to assess patellofemoral pathology, were not part of the OAI data collection protocol.
CONCLUSIONS
In conclusion, baseline knee extensor and flexor muscle weakness predicted KOA symptomatic progression in males, but not in females. This association was lost when radiographic and symptomatic progression occurred together. These results indicate that different mechanisms may drive pain in men with KOA, depending on the type of progression, and that thigh muscle strength may affect symptomatic and structural progression differently. Given the modifiable nature of muscle strength deficits, these results may identify a new window to lower the risk of symptomatic KOA progression in men.
